FRANKFURT (Reuters) – Bayer (DE:) shares rose as much as 3.5% on Monday, reaching their highest level in 14 months, after the United States government said that a $25 million glyphosate decision against the company should be reversed.
The U.S. Environmental Protection Agency and the Justice Department on Friday said in a friend of the court brief a federal appeals court should reverse a lower court verdict finding the company liable in the case of a man who blamed the weed killer by Bayer’s U.S. unit Monsanto (NYSE:) for his cancer.
Bayer denies its Roundup weed killer causes cancer.
Shares in the company, which faces multiple U.S. lawsuits that could result in overall compensation payments worth billions of dollars, rose to 74.00 euros at the Frankfurt stock exchange.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.